In a multicenter , investigator-initiated , open-label , randomized , sequential study , 38 patients with newly-diagnosed , limited-stage small-cell lung cancer were randomized to receive standard chemoradiotherapy or the same therapy plus 3,500 IU daily of bemiparin for a maximum of 26 weeks .